In this regard, it seems logical that patients with relatively well-controlled DM did not require heavy dosing with a full basal–bolus insulin regime, which in fact may be more harmful than a single dose of long-acting insulin plus a DPP4-i for covering the prandial glycemia in a patient with an otherwise reasonable beta cell reserve. This evidence concerns the gene INS and diabetes mellitus.